Company Filing History:
1 out of 2 
1 out of 1,866 
1 out of 1,128 
Years Active: 2011-2016
Title: Innovator Spotlight: Sufi Mary Thomas
Introduction
Sufi Mary Thomas is a notable inventor based in Cheswick, Pennsylvania, recognized for her significant contributions to the field of oncology through her innovative research in antisense oligonucleotides. With a total of two patents to her name, she has made strides in developing therapeutic solutions aimed at combating cancer, particularly head and neck squamous cell carcinoma.
Latest Patents
Sufi Mary Thomas's most recent patents focus on the development of antisense guanidinium peptide nucleic acid (GPNA) oligonucleotides as antitumor agents. These agents feature a distributed GPNA backbone, which demonstrates excellent cellular uptake, high specificity for target DNA or RNA, and a robust resistance to nucleases and proteases in both extracellular and intracellular environments. The patented technology suggests that systemic or intratumoral administration of antisense Epidermal Growth Factor Receptor (EGFR) GPNA oligonucleotides can effectively downmodulate EGFR levels, subsequently reducing tumor growth in head and neck squamous cell carcinoma. This groundbreaking work has shown promising results in both in vitro and in vivo studies.
Career Highlights
Over her career, Sufi has collaborated with noteworthy institutions, including the Eye & Ear Foundation and the University of Pittsburgh. Her work reflects a commitment to advancing medical treatments through innovative research and patentable inventions, marking her as a leader in her field.
Collaborations
In her professional journey, Sufi Mary Thomas has had the opportunity to work alongside esteemed colleagues, such as Jennifer Rubin Grandis and Danith H Ly. These collaborations have fostered a rich environment for innovation, enabling the development of her transformative cancer treatment technologies.
Conclusion
Sufi Mary Thomas exemplifies the spirit of innovation and dedication in the medical research field. Her patents not only signify her ingenuity but also hold the potential to significantly impact cancer therapy. As she continues her work, the scientific community watches closely, eager to see how her contributions will evolve and enhance therapeutic options for patients facing challenging diagnoses.